Guobang Pharma Ltd. (605507.SH) plans to launch the second phase of its employee stock ownership plan.

Guobang Pharma Ltd. (605507.SH) disclosed the second phase of the employee stock ownership plan (draft), with the participants including directors (excluding independent directors), senior management personnel, middle management personnel, and key technical (business) personnel who play a significant role and have an influence on the overall performance and medium to long-term development of the company (including subsidiary companies in the consolidated financial statements). The total number of participants should not exceed 270, including 8 directors (excluding independent directors) and senior management personnel participating in the stock ownership plan. The initial proposed fundraising amount for the employee stock ownership plan is not more than 185 million yuan, with employees contributing no more than 185 million yuan.